Taro Pharmaceutical
TARO
$38.03
Share price
-0.39%
Change (1 day)
4.77%
Change (1 year)
Categories
Taro Pharmaceutical (TARO) - Total debt
Total debt on the balance sheet as of March 2022 : $2.2 M
According to Taro Pharmaceutical's latest financial reports the company's total debt is $2.2 M. A company’s total debt is the sum of all current and non-current debts.
Taro Pharmaceutical - Total debt on balance sheet (from 2001 to 2022)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-03-31 | $2.2 M | 30.49% |
| 2021-03-31 | $1.68 M | 11.56% |
| 2020-03-31 | $1.51 M | |
| 2015-03-31 | $5.88 M | -67.04% |
| 2014-03-31 | $17.86 M | -37.54% |
| 2013-03-31 | $28.59 M | |
| 2011-12-31 | $44.68 M | -24.79% |
| 2010-12-31 | $59.42 M | -63.71% |
| 2009-12-31 | $0.16 B | -12.91% |
| 2008-12-31 | $0.18 B | -13.23% |
| 2007-12-31 | $0.21 B | -9% |
| 2006-12-31 | $0.23 B | -11.55% |
| 2005-12-31 | $0.26 B | -0.01% |
| 2004-12-31 | $0.26 B | 34.3% |
| 2003-12-31 | $0.20 B | 249.28% |
| 2002-12-31 | $57.39 M | 11.44% |
| 2001-12-31 | $51.5 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $39.65 B | 1,799,310.16% | 🇺🇸 USA |
 Novartis NVS | $29.20 B | 1,324,945.37% | 🇨🇭 Switzerland |
 Pfizer PFE | $34.87 B | 1,582,023.41% | 🇺🇸 USA |
 Merck MRK | $30.69 B | 1,392,413.61% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $25.89 B | 1,174,836.48% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | $21.56 B | 978,166.79% | 🇮🇱 Israel |